← Back to Search
Sialidase Significance For Cancer Progression
T. Miyagi, Kohta Takahashi, K. Hata, K. Shiozaki, K. Yamaguchi
Published 2012 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Aberrant glycosylation is a characteristic feature of cancer cells. In particular, altered sialylation is closely associated with malignant properties, including invasiveness and metastatic potential. To elucidate the molecular mechanisms underlying the aberrancy, our studies have focused on mammalian sialidase, which catalyzes the removal of sialic acid residues from glycoproteins and glycolipids. The four types of mammalian sialidase identified to date show altered expression and behave in different manners during carcinogenesis. The present review briefly summarizes results on altered expression of sialidases and their possible roles in cancer progression. These enzymes are indeed factors defining cancer malignancy and thus potential targets for cancer diagnosis and therapy.
This paper references
Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.
A. D'azzo (1982)
Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase.
T. Miyagi (1984)
Rat-liver lysosomal sialidase
T. Miyagi (1984)
Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases
N. Galjart (1988)
lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases
N-linked oligosaccharide changes with oncogenic transformation require sialylation of multiantennae.
U. Santer (1989)
Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene.
E. Easton (1991)
Bacterial sialidases--roles in pathogenicity and nutrition.
T. Corfield (1992)
Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase.
T. Miyagi (1993)
Distribution and possible roles of the highly polysialylated neural cell adhesion molecule (NCAM-H) in the developing and adult central nervous system
T. Seki (1993)
Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: sequence alignment similarities to bacterial sialidases.
J. Ferrari (1994)
Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal‐type sialidase activity
Taeko Miyagi (1994)
Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.
E. Bonten (1996)
Involvement of an endogenous sialidase in skeletal muscle cell differentiation.
K. Satô (1996)
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
S. Hakomori (1996)
Identification of a Sialidase Encoded in the Human Major Histocompatibility Complex*
C. Milner (1997)
Cloning and characterization of a sialidase from the murine histocompatibility-2 complex: low levels of mRNA and a single amino acid mutation are responsible for reduced sialidase activity in mice carrying the Neu1a allele.
M. Carrillo (1997)
Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA
S. Tokuyama (1997)
Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis
A. Pshezhetsky (1997)
Cloning and characterization of a sialidase from the murine histocompatibility-2 complex: low levels of mRNA and a single amino acid mutation are responsible for reduced sialidase activity in mice carrying the Neula allele
M.Belen Cariillo (1997)
Cloning of the cDNA and gene encoding mouse lysosomal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts.
Suleiman A. Igdoura (1998)
A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse.
R. Rottier (1998)
Sialidase gene transfection enhances epidermal growth factor receptor activity in an epidermoid carcinoma cell line, A431.
E. Meuillet (1999)
Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases.
E. Monti (1999)
Molecular Cloning and Characterization of a Plasma Membrane-associated Sialidase Specific for Gangliosides*
T. Miyagi (1999)
Molecular cloning and expression of mouse brain sialidase.
C. L. Fronda (1999)
Cloning, expression, and chromosomal mapping of a human ganglioside sialidase.
T. Wada (1999)
Molecular Cloning of Mouse Ganglioside Sialidase and Its Increased Expression in Neuro2a Cell Differentiation*
T. Hasegawa (2000)
Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane.
E. Monti (2000)
The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts.
D. Kalka (2001)
Overexpression of lysosomal‐type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells
T. Kato (2001)
Cloning, chromosomal mapping, and characteristic 5'-UTR sequence of murine cytosolic sialidase.
K. Kotani (2001)
Plasma Membrane Ganglioside Sialidase Regulates Axonal Growth and Regeneration in Hippocampal Neurons in Culture
Jose Abad Rodriguez (2001)
Intracellular Distribution of Lysosomal Sialidase Is Controlled by the Internalization Signal in Its Cytoplasmic Tail*
K. E. Lukong (2001)
Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
F. Tanaka (2001)
Differential expression of three sialidase genes in rat development.
T. Hasegawa (2001)
A Close Association of the Ganglioside-specific Sialidase Neu3 with Caveolin in Membrane Microdomains*
Y. Wang (2002)
Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression
M. Sawada (2002)
GD3 ganglioside and apoptosis.
F. Malisan (2002)
Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression
Y. Kakugawa (2002)
Molecular pathology of NEU1 gene in sialidosis
V. Seyrantepe (2003)
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells
A. Fanzani (2003)
Recruitment of Murine Neutrophils in Vivothrough Endogenous Sialidase Activity*
A. Cross (2003)
Polysialyltransferases: major players in polysialic acid synthesis on the neural cell adhesion molecule.
K. Angata (2003)
Identification and expression of Neu4, a novel murine sialidase.
Elena M. Comelli (2003)
Molecular Pathology of NEU 1 Gene in Sialidosis
V. Seyrantepe (2003)
Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation
A. Fanzani (2004)
Structure of the human cytosolic sialidase Neu2
L. Chavas (2004)
Modulation of Neuritogenesis by Ganglioside-Specific Sialidase (Neu 3) in Human Neuroblastoma NB-1 Cells
S. Proshin (2002)
Glycans and neural cell interactions
R. Kleene (2004)
The Plasma Membrane-associated Sialidase MmNEU3 Modifies the Ganglioside Pattern of Adjacent Cells Supporting Its Involvement in Cell-to-Cell Interactions*
N. Papini (2004)
Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
Y. Miura (2004)
Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family.
E. Monti (2004)
Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells*
V. Seyrantepe (2004)
Crystal Structure of the Human Cytosolic Sialidase Neu2
L. Chavas (2005)
Evidence for mitochondrial localization of a novel human sialidase (NEU4).
K. Yamaguchi (2005)
Asymmetric membrane ganglioside sialidase activity specifies axonal fate
Jorge Santos Da Silva (2005)
Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL)
N. Suzuki (2005)
Monocyte Differentiation Up-regulates the Expression of the Lysosomal Sialidase, Neu1, and Triggers Its Targeting to the Plasma Membrane via Major Histocompatibility Complex Class II-positive Compartments*
F. Liang (2006)
Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility*
S. Ueno (2006)
Epidermal growth factor-induced mobilization of a ganglioside-specific sialidase (NEU3) to membrane ruffles.
K. Yamaguchi (2006)
Lysosomal Sialidase (Neuraminidase-1) Is Targeted to the Cell Surface in a Multiprotein Complex That Facilitates Elastic Fiber Assembly*
A. Hinek (2006)
Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling.
K. Kato (2006)
Polysialic acid facilitates tumor invasion by glioma cells
鈴木 雅美 (2007)
Expression of Sialidase Neu2 in Leukemic K562 Cells Induces Apoptosis by Impairing Bcr-Abl/Src Kinases Signaling*
C. Tringali (2007)
Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites
T. Hasegawa (2007)
Down‐regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers
H. Yamanami (2007)
A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells
T. Wada (2007)
Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures.
G. Zanchetti (2007)
Neuraminidase 1 is a negative regulator of lysosomal exocytosis.
G. Yogalingam (2008)
Limited Inhibitory Effects of Oseltamivir and Zanamivir on Human Sialidases
K. Hata (2008)
Polysialic acid in the plasticity of the developing and adult vertebrate nervous system
U. Rutishauser (2008)
N-Glycans in cancer progression.
Ken S. Lau (2008)
Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage.
V. Seyrantepe (2008)
Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2.
A. Hinek (2008)
Human sialidase as a cancer marker
T. Miyagi (2008)
Enzymatic Activity of Lysosomal Carboxypeptidase (Cathepsin) A Is Required for Proper Elastic Fiber Formation and Inactivation of Endothelin-1
V. Seyrantepe (2008)
Plasma membrane-associated sialidase as a crucial regulator of transmembrane signalling.
T. Miyagi (2008)
Roles of plasma membrane-associated sialidase NEU3 in human cancers.
T. Miyagi (2008)
Regulation of Phagocytosis in Macrophages by Neuraminidase 1*
V. Seyrantepe (2009)
Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin β4
T. Uemura (2009)
Developmental Change of Sialidase Neu4 Expression in Murine Brain and Its Involvement in the Regulation of Neuronal Cell Differentiation*
K. Shiozaki (2009)
Glycobiology in the cytosol: the bitter side of a sweet world.
Yoko Funakoshi (2009)
Plasma membrane‐associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane‐treated transgenic mice
K. Shiozaki (2009)
Sialidases in vertebrates: a family of enzymes tailored for several cell functions.
E. Monti (2010)
Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility
S. Hakomori (2010)
Down regulation of membrane‐bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells
C. Mandal (2010)
Human sialidase NEU4 long and short are extrinsic proteins bound to outer mitochondrial membrane and the endoplasmic reticulum, respectively.
A. Bigi (2010)
Desialylation of insulin receptors and IGF-1 receptors by neuraminidase-1 controls the net proliferative response of L6 myoblasts to insulin.
Majid Arabkhari (2010)
J. Biol. Chem
Lysosomal sialidase ( neuraminidase1 ) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assem
A. Hinek (2010)
Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4*
K. Shiozaki (2011)
Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion.
X. Li (2011)
Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors
A. Pshezhetsky (2011)
Mammalian sialidases: physiological and pathological roles in cellular functions.
T. Miyagi (2012)
Sialidase NEU4 Hydrolyzes Polysialic Acids of Neural Cell Adhesion Molecules and Negatively Regulates Neurite Formation by Hippocampal Neurons
K. Takahashi (2012)
NEU4L sialidase overexpression promotes β‐catenin signaling in neuroblastoma cells, enhancing stem‐like malignant cell growth
C. Tringali (2012)
Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling
S. Kawamura (2012)
K Takahashi (2012)
Expression of cDNA encoding the human " protective protein " associated with 574
N J Galjart (2012)
This paper is referenced by
Evaluation of oral cancer associated glycosyltransferase expression levels in peripheral blood mononucleated cells
Mallikarjun Goni (2021)
Serum Sialylation Changes in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Patients
M. Tampa (2021)
Neu1 deficiency induces abnormal emotional behavior in zebrafish
Asami Ikeda (2021)
The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model
P. Wielgat (2021)
Pulmonary Fibrosis Serum Amyloid P in the Sera of Patients with Idiopathic Reduced Sialylation and Bioactivity of the Antifibrotic Protein
Wensheng Chen (2020)
Protein glycosylation in head and neck cancers: From diagnosis to treatment.
M. Rasheduzzaman (2020)
Reduced Sialylation and Bioactivity of the Antifibrotic Protein Serum Amyloid P in the Sera of Patients with Idiopathic Pulmonary Fibrosis
Wensheng Chen (2020)
Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy
P. Wielgat (2020)
Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
P. Wielgat (2020)
Inhibiting Sialidase-Induced TGF-β1 Activation Attenuates Pulmonary Fibrosis in Mice
Tejas R. Karhadkar (2020)
Insights into the role of sialylation in cancer progression and metastasis
Christopher Dobie (2020)
Insight in Adhesion Protein Sialylation and Microgravity Dependent Cell Adhesion—An Omics Network Approach
Thomas J Bauer (2020)
Establishment and characterization of Neu1-knockout zebrafish and its abnormal clinical phenotypes.
K. Okada (2020)
Tools to study and target the Siglec–sialic acid axis in cancer
H. Läubli (2020)
Membrane Ganglioside-Specific Neuraminidase 3 (NEU3) Regulates GM3 Signaling
Cheorl-Ho Kim (2020)
Directed Evolution of a Remarkably Efficient Kdnase from a Bacterial Neuraminidase.
Saeideh Shamsi Kazem Abadi (2019)
Comprehensive Profiling of Surface Gangliosides Extracted from Various Cell Lines by LC-MS/MS
Jua Lee (2019)
Attenuated Pulmonary Fibrosis in Sialidase-3 Knockout (Neu3-/-) Mice.
Tejas R. Karhadkar (2019)
Filter Beacon: A Gating-Free Architecture for Protein-Specific Glycoform Imaging on Cell Surface.
Yiran Liu (2019)
Fluorogenic Probes for Accurate in Situ Imaging of Viral and Mammalian Sialidases.
Yuuki Kurebayashi (2019)
Gangliosides: methods and protocols
Sandro Sonnino and Alessandro Prinetti. (2019)
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells.
Flavia Orizio (2019)
Biological and Pathological Roles of Ganglioside Sialidases.
T. Miyagi (2018)
INTEGRATING MICROSCALE ENZYME AND LECTIN REACTIONS USING NANOGEL ASSISTED CAPILLARY ELECTROPHORESIS
S. Gattu (2018)
Sialylation is involved in cell fate decision during development, reprogramming and cancer progression
Fenjie Li (2018)
Deregulation of sialidases in human normal and tumor tissues.
M. Forcella (2017)
Use of Sialic Acid as a Complementary Method in the Cytological Diagnosis: Preliminary Study
A. Rocher (2018)
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
I. Ferreira (2018)
Mahanine drives pancreatic adenocarcinoma cells into endoplasmic reticular stress-mediated apoptosis through modulating sialylation process and Ca2+-signaling
Sayantani Sarkar Bhattacharya (2018)
Serum sialylation changes in cancer
Z. Zhang (2018)
Gangliosides and Tumors.
R. Kannagi (2018)
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
Tejas R. Karhadkar (2017)See more